Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy

Structural and functional insights into enzymes of the vitamin K cycle

(2016) J.-K. Tie et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

C3435T polymorphism of MDR1 gene with warfarin resistance

(2013) Yeongsic Kim et al.   CLINICA CHIMICA ACTA

An integrated map of genetic variation from 1,092 human genomes

(2012)   NATURE

Prediction of warfarin dose: why, when and how?

(2012) Niclas Eriksson et al.   PHARMACOGENOMICS

Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients

(2011) Nassr Eldin M. A. Shrif et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

(2010) P Lenzini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of Single-Dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers

(2010) A Frymoyer et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction

(2010) Marianne K. Kringen et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Interactive Modeling for Ongoing Utility of Pharmacogenetic Diagnostic Testing: Application for Warfarin Therapy

(2009) M. W. Linder et al.   CLINICAL CHEMISTRY

Genotypes Associated With Reduced Activity of VKORC1 and CYP2C9 and Their Modification of Acenocoumarol Anticoagulation During the Initial Treatment Period

(2009) M Teichert et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

(2009) S.-F. Zhou et al.   CURRENT MEDICINAL CHEMISTRY

Pharmacogenetics of Oral Anticoagulant Therapy

(2009) T. Schalekamp et al.   CURRENT PHARMACEUTICAL DESIGN

Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients

(2009) Masako Ohno et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients

(2009) Sheng-Wen Huang et al.   Pharmacogenetics and Genomics

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

Influence ofCYP2C9andVKORC1on warfarin dose, anticoagulation attainment and maintenance among European–Americans and African–Americans

(2008) Nita A Limdi et al.   PHARMACOGENOMICS

Warfarin-induced bleeding complications — clinical presentation and therapeutic options

(2008) Christian J. Wiedermann et al.   THROMBOSIS RESEARCH